Mae Zakhour

Mae Zakhour practices at Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health.

Mae Zakhour's NPI, 1427342294, was assigned on June 8, 2011. Mae Zakhour graduated from University of Texas Southwestern Medical School at Dallas in 2009. Mae Zakhour holds California license A115768.

Mae Zakhour's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth, at 100 Michigan St NE, Grand Rapids, MI 49503 in Kent County. The practice phone is (616) 391-1774.

Mae Zakhour's primary practice is Corewell Health Grand Rapids Hospitals - Butterworth in Grand Rapids, Michigan, part of Corewell Health. Mae Zakhour is also affiliated with Corewell Health Lakeland Hospitals - Saint Joseph Hospital. The medical group on file is Corewell Health Medical Group West. Dmand AI also links Mae Zakhour to 3 more hospitals, 6 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mae Zakhour practices, 8 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Mae Zakhour's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Mae Zakhour is licensed in California.

CMS data shows 91 Medicare services from Mae Zakhour across 3 procedure codes in 2024, all of them office visits, for 77 Medicare patients. Medicare paid $10,521 for them. Every service was in an office.

CMS counts 77 Medicare patients who saw Mae Zakhour in 2024. The largest group is 65 to 74, with 44 patients. 65% of them have high blood pressure, and 65% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Mae Zakhour's median patient age at 61, with 100% women.

In 2024, Mae Zakhour wrote 297 Medicare Part D claims for 81 patients. 91% of them were for generic drugs. CMS names the drug for 163 of them, across 7 drugs with 11 or more claims each, at $9,373 in total drug cost. In 2023, CMS named 81 claims across 4 drugs.

Mae Zakhour accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mae Zakhour as offering telehealth. CMS counts 12 procedures of removal of the uterus by Mae Zakhour, more than 86% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Mae Zakhour, published from 2016 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Genetic Counseling and Genetic Testing. Mae Zakhour has published most often in Gynecol Oncol. Mae Zakhour's most frequent co-authors are Joshua Garrett Cohen, MD, Malaika Williams Amneus, MD and Chisa Aoyama, MD.

Dmand AI links Mae Zakhour to 3 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms and Vulvar Neoplasms.

CMS Open Payments shows 38 general payments to Mae Zakhour from 17 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,722.

Mae Zakhour graduated from University of Texas Southwestern Medical School at Dallas in 2009.